Targeting EGFR in Triple Negative Breast Cancer

Our preliminary data show that erlotinib inhibits Triple-negative breast cancer (TNBC) in a xenograft model. However, inhibition of metastasis by erlotinib is accompanied by nonspecific effects because erlotinib can inhibit other kinases; thus, more direct targets that regulate TNBC metastasis need...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Naoto T., Zhang, Dongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119395/
https://www.ncbi.nlm.nih.gov/pubmed/21716849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119395/
https://www.ncbi.nlm.nih.gov/pubmed/21716849

Ejemplares similares